As the repressor protein CtBP1 is considered as a therapeutic target in various cancer types [17] and might have a role specifically for EVI1 overexpressing malignancies, these observations need to be considered when targeting CtBP1 interactions therapeutically. This evidence concerns the gene CTBP1 and cancer.